Bank of America Securities Remains a Buy on Elevance Health (ELV)
TipRanks (Thu, 4-Jun 6:58 AM ET)
AI Analyst Picks 3 Best ETFs with 10%+ Upside, 6/1/2026
TipRanks (Mon, 1-Jun 1:01 PM ET)
Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
Business Wire (Wed, 27-May 6:46 AM ET)
Elevance Health Advances Efforts to Close Critical Gaps in Mental Health Care
Business Wire (Mon, 4-May 2:10 PM ET)
Elevance Health Names Best in Class Primary Care Practices in Care Provider Recognition Program
Business Wire (Fri, 1-May 8:00 AM ET)
Business Wire (Thu, 30-Apr 8:00 AM ET)
Globe Newswire (Wed, 22-Apr 8:00 PM ET)
Elevance Health Boosts Full-Year Outlook as Strong Operations Drive Record Adjusted EPS
Market Chameleon (Wed, 22-Apr 3:13 AM ET)
Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance
Business Wire (Wed, 22-Apr 6:00 AM ET)
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Elevance Health trades on the NYSE stock market under the symbol ELV.
As of June 4, 2026, ELV stock price climbed to $409.02 with 400,587 million shares trading.
ELV has a beta of 0.93, meaning it tends to be less sensitive to market movements. ELV has a correlation of 0.09 to the broad based SPY ETF.
ELV has a market cap of $88.82 billion. This is considered a Large Cap stock.
Last quarter Elevance Health reported $49 billion in Revenue and $12.58 earnings per share. This beat revenue expectation by $2 billion and exceeded earnings estimates by $1.84.
In the last 3 years, ELV traded as high as $567.26 and as low as $273.71.
The top ETF exchange traded funds that ELV belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
ELV has underperformed the market in the last year with a return of +9.7%, while SPY returned +28.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ELV shares. However, ELV has outperformed the market in the last 3 month and 2 week periods, returning +44.6% and +3.2%, while SPY returned +11.3% and +1.9%, respectively. This indicates ELV has been having a stronger performance recently.
ELV support price is $384.56 and resistance is $397.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELV shares will trade within this expected range on the day.